NCT04873362 · Interventional trial
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
Overall registry status Active not recruiting
Phase 3
Conditions Breast Cancer
Delaware Valley sites
- Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory